Dosage & Administration
Dosage Form Enema Route of Administration Rectal Visual Identification A colourless, opalescent and viscous preparation.
Microlax Enema
FDA Label NDC 84177-0020
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Media Networks Sydney Pty Limited for the product Microlax Enema (NDC 84177-0020). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding dosage & administration, warnings, inactive ingredient, indications & usage, otc - keep out of reach of children, otc - purpose, otc - active ingredient, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Warnings
No Warnings included on Record
Inactive Ingredient
glycerol purified water sorbic acid
Indications & Usage
Permitted Indications No Permitted Indications included on Record Indication Requirements No Indication Requirements included on Record
Otc - Keep Out Of Reach Of Children
keep out of reach of children
Otc - Purpose
Single Medicine Product Specific Indications Rectal constipation, faecal incontinence; preparation for X-ray examination and rectoscopy
Otc - Active Ingredient
Active Ingredients
sodium citrate dihydrate 90 mg/mL
sodium lauryl sulfoacetate 9 mg/mL
sorbitol 625 mg/mL
Package Label.Principal Display Panel
Content Of Labeling (41zgrthv6ql. Ac)
* Please review the disclaimer below.
